Published in Diabetes Care on October 01, 2005
A review of current treatment strategies for gestational diabetes mellitus. Drugs Context (2015) 0.83
Perinatal outcomes associated with the use of glargine during pregnancy. Diabet Med (2008) 0.82
The use of insulin glargine with gestational diabetes mellitus. Diabetes Care (2006) 0.78
The insulin analog glargine during an unplanned pregnancy. Wien Klin Wochenschr (2006) 0.75
Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care (2005) 3.55
The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient. Int J Clin Oncol (2006) 1.20
Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. Diabetes Technol Ther (2003) 1.16
Back to basics in diagnosing diabetic polyneuropathy with the tuning fork! Diabetes Care (2005) 1.15
Management of late-preterm premature rupture of membranes: the PPROMEXIL-2 trial. Am J Obstet Gynecol (2012) 1.01
HDL-cholesterol level and cortisol response to synacthen in critically ill patients. Intensive Care Med (2003) 0.97
Term breech presentation in The Netherlands from 1995 to 1999: mortality and morbidity in relation to the mode of delivery of 33824 infants. BJOG (2003) 0.96
Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care (2003) 0.95
Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies. Diabetes Res Clin Pract (2007) 0.90
Induction of labour versus expectant monitoring in women with pregnancy induced hypertension or mild preeclampsia at term: the HYPITAT trial. BMC Pregnancy Childbirth (2007) 0.89
The impact of new insights and revised practice guidelines on prescribing drugs in the treatment of Type 2 diabetes mellitus. Br J Clin Pharmacol (2006) 0.85
Cross-border flow of health information: is 'privacy by design' enough? Privacy performance assessment in EUBIROD. Eur J Public Health (2012) 0.83
Effects of microdialysis catheter insertion into the subcutaneous adipose tissue assessed by the SCGM1 system. Diabetes Technol Ther (2003) 0.81
[Treatment of asthma during pregnancy]. Ned Tijdschr Geneeskd (2009) 0.81
Identifying targets to improve treatment in type 2 diabetes; the Groningen Initiative to aNalyse Type 2 diabetes Treatment (GIANTT) observational study. Pharmacoepidemiol Drug Saf (2010) 0.81
Improving metabolic control in sub-optimally controlled subjects with Type 1 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Res Clin Pract (2006) 0.81
[Quality of the treatment of type 2 diabetes: results from the GIANTT project 2004-2007]. Ned Tijdschr Geneeskd (2010) 0.79
Well being of obstetric patients on minimal blood transfusions (WOMB trial). BMC Pregnancy Childbirth (2010) 0.79
Alternative-site blood glucose measurement at the abdomen. Diabetes Care (2002) 0.78
Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term. Acta Obstet Gynecol Scand (2014) 0.75